Syngene International (NSE:SYNGENE) Cyclically Adjusted Revenue per Share: ₹75.18 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:SYNGENE Syngene International Ltd NSE:SYNGENE
86 GF Score
Price ₹398.55
GF Value ₹723.76
Valuation Significantly Undervalued
! 4 Warning Signs
View Full Analysis

What is Syngene International Cyclically Adjusted Revenue per Share?

Syngene International NSE:SYNGENE -2.14% 86 Cyclically Adjusted Revenue per Share is ₹75.18 as of Jun. 2026. GuruFocus rates NSE:SYNGENE with a GF Score™ of 86/100 and a GF Value™ of ₹723.76 (Significantly Undervalued). The stock has 4 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Syngene International's adjusted revenue per share for the three months ended in Jun. 2026 was ₹17.991. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is ₹75.18 for the trailing ten years ended in Jun. 2026.

During the past 12 months, Syngene International's average Cyclically Adjusted Revenue Growth Rate was 10.50% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 10.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Syngene International was 10.80% per year. The lowest was 10.80% per year. And the median was 10.80% per year.

As of today (2026-08-25), Syngene International's current stock price is ₹398.55. Syngene International's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2026 was ₹75.18. Syngene International's Cyclically Adjusted PS Ratio of today is 5.30.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Syngene International was 15.30. The lowest was 5.16. And the median was 11.55.


Syngene International  (NSE:SYNGENE) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Syngene International's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=398.55/75.18
=5.30

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Syngene International was 15.30. The lowest was 5.16. And the median was 11.55.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Syngene International Cyclically Adjusted Revenue per Share Related Terms


Syngene International Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Syngene International's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Syngene International Cyclically Adjusted Revenue per Share Chart

Syngene International Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 53.69 58.93 65.42 73.05

Syngene International Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 67.58 69.81 71.47 73.05 75.18

NSE:SYNGENE vs TMO, DHR, IDXX: Cyclically Adjusted Revenue per Share Comparison

For the Diagnostics & Research subindustry, Syngene International's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Syngene International Cyclically Adjusted PS Ratio vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Syngene International's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Syngene International's Cyclically Adjusted PS Ratio falls into.


NSE:SYNGENE
86GF Score
Syngene International Ltd NSE:SYNGENE
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Syngene International Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Syngene International's adjusted Revenue per Share data for the three months ended in Jun. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=17.991/167.3573*167.3573
=17.991

Current CPI (Jun. 2026) = 167.3573.

Syngene International Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201609 7.646 105.961 12.076
201612 8.182 105.196 13.017
201703 7.338 105.196 11.674
201706 7.348 107.109 11.481
201709 8.434 109.021 12.947
201712 9.763 109.404 14.935
201803 10.288 109.786 15.683
201806 10.181 111.317 15.306
201809 10.532 115.142 15.308
201812 11.758 115.142 17.090
201903 10.659 118.202 15.092
201906 10.613 120.880 14.694
201909 11.678 123.175 15.867
201912 13.062 126.235 17.317
202003 11.939 124.705 16.022
202006 10.613 127.000 13.986
202009 12.975 130.118 16.688
202012 14.584 130.889 18.647
202103 14.043 131.771 17.836
202106 14.536 134.084 18.143
202109 14.912 135.847 18.371
202112 15.727 138.161 19.050
202203 17.030 138.822 20.531
202206 15.960 142.347 18.764
202209 19.052 144.661 22.041
202212 19.415 145.763 22.291
202303 21.994 146.865 25.063
202306 20.073 150.280 22.354
202309 22.655 151.492 25.028
202312 21.204 152.924 23.205
202403 19.857 153.035 21.715
202406 19.612 155.789 21.068
202409 22.170 157.882 23.501
202412 23.467 158.323 24.806
202503 25.325 157.552 26.901
202506 21.686 159.755 22.718
202509 22.663 162.289 23.371
202512 22.622 163.281 23.187
202603 25.720 164.272 26.203
202606 17.991 167.357 17.991

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of ₹75.18 mean?
Syngene International (NSE:SYNGENE) has a Cyclically Adjusted Revenue per Share of ₹75.18 as of Jun. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Syngene International and its competitors.
Is Syngene International's Cyclically Adjusted Revenue per Share too high?
Syngene International's current Cyclically Adjusted Revenue per Share is ₹75.18. Overall, Syngene International has a GF Score™ of 86/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Syngene International's Cyclically Adjusted Revenue per Share compare to TMO and DHR?
Syngene International's Cyclically Adjusted Revenue per Share of ₹75.18 can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Medical Diagnostics & Research company?
A good Cyclically Adjusted Revenue per Share depends on the Medical Diagnostics & Research industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Syngene International and its competitors. Syngene International's current Cyclically Adjusted Revenue per Share is ₹75.18. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Syngene International stock overvalued right now?
Based on GuruFocus' analysis, Syngene International (NSE:SYNGENE) is currently considered Significantly Undervalued. The stock's GF Value™ is ₹723.76, compared to a current price of ₹398.55 — trading 44.9% below its estimated fair value. The current Cyclically Adjusted Revenue per Share is ₹75.18. Syngene International's overall GF Score™ is 86/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Syngene International (NSE:SYNGENE), the current Cyclically Adjusted Revenue per Share is ₹75.18 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Syngene International (NSE:SYNGENE) Overvalued in 2026?

Based on GuruFocus' analysis, Syngene International stock appears to be undervalued. The current stock price of ₹398.55 is trading 44.9% below its estimated GF Value™ of ₹723.76. GuruFocus considers Syngene International to be Significantly Undervalued.

Key valuation signals for NSE:SYNGENE:

  • Cyclically Adjusted Revenue per Share: ₹75.18
  • GF Value™: ₹723.76 vs. price of ₹398.55 (44.9% below fair value)
  • GF Score™: 86/100 with 4 warning signs

No single metric tells the full story. See the NSE:SYNGENE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Syngene International Business Description

Other Exchanges 539268:India
Address Jigani Link Road, Biocon SEZ, Biocon Park, Plot No. 2 and 3, IV Phase, Bommasandra Industrial Area, Bangalore, KA, IND, 560 099
Syngene International Ltd is a contract research and manufacturing organization in India. It supports research and development programs, from lead generation to clinical and commercial supplies. The Company is engaged in a single operating segment of providing contract research and manufacturing services. The company operates in India, the United States of America and other countries, of which a majority of the revenue is derived from the USA. The company receives revenue by providing contract research and manufacturing services. It offers services such as Oligonucleotide synthesis, Bioinformatics, Clinical development services, polymer research, chemical development, safety assessment, discovery chemistry, discovery biology, and others.
86GF Score

Get the complete analysis for NSE:SYNGENE

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹398.55
Price
₹723.76
GF Value